Details of the Drug

General Information of Drug (ID: DMD3LGL)

• Drug Name: BUTIXOCORT
• Synonyms: JO-1717; Butixocort; 11beta,17-Dihydroxy-21-mercaptopregn-4-ene-3,20-dione 17-butyrate; 17-Butanoyloxy-11beta-hydroxy-21-mercaptopregn-4-ene-3,20-dione

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Discontinued in Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C25H36O5S
  Canonical SMILES: CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CS
  InChI: InChI=1S/C25H36O5S/c1-4-5-21(29)30-25(20(28)14-31)11-9-18-17-7-6-15-12-16(26)8-10-23(15,2)22(17)19(27)13-24(18,25)3/h12,17-19,22,27,31H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1
  InChIKey: HOAKOHHSHOCDLI-TUFAYURCSA-N
• Cross-matching ID:
  PubChem CID: 189904
  CAS Number: 120815-74-9
  TTD ID: D0UO2N

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002075)